Novabridge Biosciences Stock Market Value
| NBP Stock | 3.28 0.03 0.92% |
| Symbol | NovaBridge |
Can Biotechnology industry sustain growth momentum? Does NovaBridge have expansion opportunities? Factors like these will boost the valuation of NovaBridge Biosciences. Anticipated expansion of NovaBridge directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating NovaBridge Biosciences demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.32) |
NovaBridge Biosciences's market price often diverges from its book value, the accounting figure shown on NovaBridge's balance sheet. Smart investors calculate NovaBridge Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since NovaBridge Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between NovaBridge Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding NovaBridge Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, NovaBridge Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NovaBridge Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NovaBridge Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NovaBridge Biosciences.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in NovaBridge Biosciences on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding NovaBridge Biosciences or generate 0.0% return on investment in NovaBridge Biosciences over 90 days. NovaBridge Biosciences is related to or competes with Aprea Therapeutics, Adial Pharmaceuticals, Kiora Pharmaceuticals, Cardio Diagnostics, and Phio Pharmaceuticals. NovaBridge Biosciences is entity of United States More
NovaBridge Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NovaBridge Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NovaBridge Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 18.5 | |||
| Value At Risk | (6.26) | |||
| Potential Upside | 5.09 |
NovaBridge Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NovaBridge Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NovaBridge Biosciences' standard deviation. In reality, there are many statistical measures that can use NovaBridge Biosciences historical prices to predict the future NovaBridge Biosciences' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.36) |
NovaBridge Biosciences February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.35) | |||
| Mean Deviation | 3.04 | |||
| Coefficient Of Variation | (1,281) | |||
| Standard Deviation | 3.94 | |||
| Variance | 15.52 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.36) | |||
| Maximum Drawdown | 18.5 | |||
| Value At Risk | (6.26) | |||
| Potential Upside | 5.09 | |||
| Skewness | (0.14) | |||
| Kurtosis | 0.8419 |
NovaBridge Biosciences Backtested Returns
NovaBridge Biosciences has Sharpe Ratio of -0.0439, which conveys that the firm had a -0.0439 % return per unit of risk over the last 3 months. NovaBridge Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NovaBridge Biosciences' Risk Adjusted Performance of (0.05), standard deviation of 3.94, and Mean Deviation of 3.04 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.87, which conveys possible diversification benefits within a given portfolio. NovaBridge Biosciences returns are very sensitive to returns on the market. As the market goes up or down, NovaBridge Biosciences is expected to follow. At this point, NovaBridge Biosciences has a negative expected return of -0.18%. Please make sure to verify NovaBridge Biosciences' value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if NovaBridge Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.08 |
Virtually no predictability
NovaBridge Biosciences has virtually no predictability. Overlapping area represents the amount of predictability between NovaBridge Biosciences time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NovaBridge Biosciences price movement. The serial correlation of 0.08 indicates that barely 8.0% of current NovaBridge Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Pair Trading with NovaBridge Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NovaBridge Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBridge Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with NovaBridge Stock
Moving against NovaBridge Stock
| 0.77 | VALN | Valneva SE ADR | PairCorr |
| 0.64 | DNLI | Denali Therapeutics Earnings Call This Week | PairCorr |
| 0.64 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.6 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.57 | GXEA | Galapagos NV | PairCorr |
The ability to find closely correlated positions to NovaBridge Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NovaBridge Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NovaBridge Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NovaBridge Biosciences to buy it.
The correlation of NovaBridge Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NovaBridge Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NovaBridge Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NovaBridge Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for NovaBridge Stock Analysis
When running NovaBridge Biosciences' price analysis, check to measure NovaBridge Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBridge Biosciences is operating at the current time. Most of NovaBridge Biosciences' value examination focuses on studying past and present price action to predict the probability of NovaBridge Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBridge Biosciences' price. Additionally, you may evaluate how the addition of NovaBridge Biosciences to your portfolios can decrease your overall portfolio volatility.